ロード中...
Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants
BACKGROUND: "Evergreening" refers to the numerous strategies whereby owners of pharmaceutical products use patent laws and minor drug modifications to extend their monopoly privileges on the drug. We aimed to evaluate the impact of evergreening through the case study of the antidepressant...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3520785/ https://ncbi.nlm.nih.gov/pubmed/23167972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-10-142 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|